The pause-and-check question
What would make me pause an offer?
Put the care assessment, the product, and the follow-up plan beside the price. Ask for clear answers before making a commitment.
Product and safety checks: as of September 2026.
What if severe allergy symptoms appear?
A severe allergic reaction can develop quickly and can be life-threatening.
MedlinePlus lists difficulty swallowing, difficulty breathing, and a swollen tongue or face among the symptoms.
MedlinePlus advises getting emergency help or going to the closest emergency room when an allergic reaction causes severe symptoms.
Use that as an urgent-help signal, not as a way to diagnose yourself.
Read the urgent-help and reporting sourcesCheck the care and the product before committing
Is care being skipped?
It breaks federal law to dispense prescription medicine when there is no valid prescription.
The NC Medical Board rejects prescribing from only a set of online form answers, with no way to ask you more questions.
A form can be part of care, but the health professional needs a way to ask for more details about your health.
The Food and Drug Administration (FDA), which regulates US medicines, flags services lacking a licensed doctor for questions once the medicine arrives.
A question to bring
Who is responsible for assessing me and answering concerns later?
Does the approval claim add up?
Compounding means making a medicine to order. Calling that medicine FDA-approved is false.
FDA registration means the maker has entered its facility in the FDA’s records. Listing the facility gives no FDA approval to the place or its medicines.
The FDA also says an NDC number, a product code in a government directory, does not establish approval.
Ask for the exact product and its approval record, rather than treating a seal as the answer.
Sort out the medicine’s statusCan I trust a research label or a pharmacy name?
The FDA warns against unapproved weight-drug products marketed to people under research labels; they have unknown quality and could harm people.
Semaglutide and tirzepatide are ingredients in medicines used for diabetes or weight management.
The FDA has also found false labels on made-to-order versions of these medicines, with some naming pharmacies that are not real.
Its warning signs include damaged packaging, missing instructions, and a pharmacy name that appears false.
A question to bring
Does the pharmacy in the board record match the name I was given and the name on the label?
Which risks belong in my care discussion?
Off-label means using an approved medicine to treat something outside the uses listed in its FDA approval.
The NC Medical Board expects health professionals offering new or off-label treatments to explain benefits, risks, costs, and what remains uncertain.
The FDA has received reports of people harmed, possibly from mistakes with the amount of made-to-order semaglutide they injected. Some needed hospital care.
The reports include patients measuring the wrong amount and health professionals calculating the amount incorrectly.
- What problems are known for this exact medicine?
- How does my health history change that discussion?
- What instructions will the person writing the prescription and the pharmacist explain to me?
- Who do I reach if the label or instructions are unclear?
A next question
Bring the open questions to a care visit